Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 November 2003, Vol. 102, No. 10, pp. 3668-3674.
Prepublished online as a Blood First Edition Paper on July 10, 2003; DOI 10.1182/blood-2003-05-1408.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-05-1408v1
102/10/3668    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuppner, M. C.
Right arrow Articles by Issels, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuppner, M. C.
Right arrow Articles by Issels, R. D.
Related Collections
Right arrow Immunobiology
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

Ifosfamide impairs the allostimulatory capacity of human dendritic cells by intracellular glutathione depletion

Maria C. Kuppner, Anabel Scharner, Valeria Milani, Christoph von Hesler, Katharina E. Tschöp, Oksana Heinz, and Rolf D. Issels

From the Klinikum Grosshadern, Medical Clinic III, Ludwig-Maximillians-University, Munich, Germany; GSF, National Research Center for Environment and Health, Institute of Molecular Immunology, Munich, Germany; and the Clinical Cooperation Group on Hyperthermia, Ludwig-Maximillians-University, Munich, Germany.

Ifosfamide, a clinically potent chemotherapeutic agent, causes the depletion of intracellular glutathione (GSH) levels in various cell types. GSH is the major intracellular reductant against oxidative stress. 4-Hydroxyifosfamide (4-OH-IF), the activated form of ifosfamide, depletes GSH levels in T cells and natural killer (NK) cells; this is accompanied by a decrease in T-cell and NK-cell function. Here we demonstrate for the first time that human monocyte-derived dendritic cells (DCs) express higher constitutive levels of GSH and are less sensitive to 4-OH-IF-induced GSH depletion than T cells and NK cells. Treatment of DCs with 4-OH-IF significantly reduced their ability to stimulate allogeneic T-cell proliferation and interferon-{gamma} (IFN-{gamma}) production. Ifosfamide also decreased DC interleukin-12p70 (IL-12p70) production after stimulation with lipopolysaccharide (LPS) and IFN-{gamma}. The decrease in allostimulatory capacity and in IFN-{gamma} and IL-12 production correlated with a decrease in intracellular GSH in the DCs. The responses could be restored by reconstituting DC GSH levels with glutathione monoethyl ester (GSH-OEt). 4-OH-IF had no inhibitory effect on the ability of DCs to present exogenously added tyrosinase peptide to tyrosinase-specific cytotoxic T lymphocytes (CTLs). These studies suggest that in cancer patients treated with ifosfamide, protection strategies based on glutathione reconstitution may enhance DC function. (Blood. 2003;102: 3668-3674)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. A. Williams, T. Rangasamy, S. M. Bauer, S. Killedar, M. Karp, T. W. Kensler, M. Yamamoto, P. Breysse, S. Biswal, and S. N. Georas
Disruption of the Transcription Factor Nrf2 Promotes Pro-Oxidative Dendritic Cells That Stimulate Th2-Like Immunoresponsiveness upon Activation by Ambient Particulate Matter
J. Immunol., October 1, 2008; 181(7): 4545 - 4559.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Agrawal, P. Kaushal, S. Agrawal, S. Gollapudi, and S. Gupta
Thimerosal induces TH2 responses via influencing cytokine secretion by human dendritic cells
J. Leukoc. Biol., February 1, 2007; 81(2): 474 - 482.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Zhang, M. A. Alston, H. Huang, and R. L. Rabin
Human T cell cytokine responses are dependent on multidrug resistance protein-1
Int. Immunol., March 1, 2006; 18(3): 485 - 493.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020